Table 2.
Clinicopathologic characteristics of adenosquamous carcinoma tumors in patient cohort. Staging is based on American Joint Committee on Cancer (AJCC) Guidelines for colon cancer. (MMR = mismatch repair).
| Primary Tumor Location (n, %) | |
|---|---|
| Cecum/Ascending Colon | 6 (46.2%) |
| Transverse Colon | 2 (15.4%) |
| Splenic Flexure | 2 (15.4%) |
| Descending Colon | 2 (15.4%) |
| Sigmoid Colon | 1 (7.7%) |
| Stage at Diagnosis (n, %) | |
| II | 1 (7.7%) |
| III | 6 (46.2%) |
| IV | 6 (46.2%) |
| Pathology (n, %) | |
| Moderately Differentiated | 6 (46.2%) |
| Poorly Differentiated | 7 (58.3%) |
| MMR status (n, %) | |
| Proficient | 7 (58.3%) |
| Deficient | 1 (7.7%) |
| Unknown | 5 (38.5%) |